|
⚲
|
| C2 Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001399463 |
| Sale | 2009-06-02 ($4.9 M Offered, $3.0 M Sold) |
| Fund | |
| Phone | 4158288280 |
| Address | 740 Paradise Way Redwood City, 94062 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Rick Williams | |
| Frank Watkins | |
| Peter Garciameza |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Companyon Smartvid.io Series A-1, A Series of Assure Labs 20
✚
|
0.0 | |
|
Compound Advantage: 21st Century Themes, LLC
✚
|
0.0 | |
|
Compound Advantage: Rebounder Fund, LLC
✚
|
0.0 | |
|
Malloy Andrew T
✚
|
0.0 | |
|
Maloy David
✚
|
0.0 | |
|
Malpass Scott Charles
✚
|
0.0 | |
|
Mammoth Private Capital, LLC - Health & Tech Fund Series 4
✚
|
0.0 | |
|
Mana Ventures, LP - B1
✚
|
0.0 | |
|
Man TargetRisk Global Equities
✚
|
0.0 | |
|
Companyon Disruptor Beam Syndicate, A Series of Assure Labs
✚
|
0.0 |